Bone Marrow Edema Syndrome of the Medial Femoral Condyle Treated With Extracorporeal Shock Wave Therapy: A Clinical and MRI Retrospective Comparative Study

M Vitali, N Naim Rodriguez, Alberto Pedretti, A Drossinos, P Pironti, G Di Carlo, G Fraschini

Research output: Contribution to journalArticle

Abstract

Objective: To determine the validity of extracorporeal shock wave therapy (ESWT) in the treatment of bone marrow edema (BME) of the medial condyle of the knee. Design: Retrospective. Setting: Orthopedic Surgery outpatient clinic. Participants: Symptomatic patients (N=56) affected by BME of the medial condyle of the knee. Patients were equally divided into an ESWT-treated group and a control group, which was managed conservatively. Interventions: ESWT delivery to the medial condyle of the affected knee. Main Outcome Measures: Clinical and functional assessment of the knee was performed with the use of the clinical and functional scores of the Knee Society Score (KSS). Pain was measured with the visual analog scale (VAS). BME area was measured with magnetic resonance imaging (MRI) before treatment and at 4 months’ follow-up. Results: Clinical evaluation of patients at final follow-up of 4 months posttreatment showed a significant improvement (P <.0001) of symptoms and knee functionality, both for range of motion and strength in both groups. VAS values were significantly improved (P <.0001) in both groups, with 3 patients in the ESWT group being pain-free (VAS=0) at 4 months’ follow-up. At 4 months, MRI assessments on both sagittal and coronal views showed a significant reduction in BME in the ESWT group compared with the control group. Conclusions: Our findings show that ESWT is a valid nonpharmacologic and noninvasive therapy for spontaneous BME of the medial condyle that improves the affected vascular and metabolic state present in this pathologic disorder through its metabolic mechanisms of action. © 2017 American Congress of Rehabilitation Medicine
Original languageEnglish
Pages (from-to)873-879
Number of pages7
JournalArchives of Physical Medicine and Rehabilitation
Volume99
Issue number5
DOIs
Publication statusPublished - 2018

Fingerprint

Convulsive Therapy
Thigh
Edema
Retrospective Studies
Bone Marrow
Magnetic Resonance Imaging
Knee
Bone and Bones
Visual Analog Scale
Control Groups
Articular Range of Motion
Ambulatory Care Facilities
Orthopedics
Blood Vessels
Therapeutics
Rehabilitation
Medicine
Outcome Assessment (Health Care)
Pain

Cite this

Bone Marrow Edema Syndrome of the Medial Femoral Condyle Treated With Extracorporeal Shock Wave Therapy: A Clinical and MRI Retrospective Comparative Study. / Vitali, M; Naim Rodriguez, N; Pedretti, Alberto; Drossinos, A; Pironti, P; Di Carlo, G; Fraschini, G.

In: Archives of Physical Medicine and Rehabilitation, Vol. 99, No. 5, 2018, p. 873-879.

Research output: Contribution to journalArticle

@article{1a592d4a3a8641b69416a596595eae3b,
title = "Bone Marrow Edema Syndrome of the Medial Femoral Condyle Treated With Extracorporeal Shock Wave Therapy: A Clinical and MRI Retrospective Comparative Study",
abstract = "Objective: To determine the validity of extracorporeal shock wave therapy (ESWT) in the treatment of bone marrow edema (BME) of the medial condyle of the knee. Design: Retrospective. Setting: Orthopedic Surgery outpatient clinic. Participants: Symptomatic patients (N=56) affected by BME of the medial condyle of the knee. Patients were equally divided into an ESWT-treated group and a control group, which was managed conservatively. Interventions: ESWT delivery to the medial condyle of the affected knee. Main Outcome Measures: Clinical and functional assessment of the knee was performed with the use of the clinical and functional scores of the Knee Society Score (KSS). Pain was measured with the visual analog scale (VAS). BME area was measured with magnetic resonance imaging (MRI) before treatment and at 4 months’ follow-up. Results: Clinical evaluation of patients at final follow-up of 4 months posttreatment showed a significant improvement (P <.0001) of symptoms and knee functionality, both for range of motion and strength in both groups. VAS values were significantly improved (P <.0001) in both groups, with 3 patients in the ESWT group being pain-free (VAS=0) at 4 months’ follow-up. At 4 months, MRI assessments on both sagittal and coronal views showed a significant reduction in BME in the ESWT group compared with the control group. Conclusions: Our findings show that ESWT is a valid nonpharmacologic and noninvasive therapy for spontaneous BME of the medial condyle that improves the affected vascular and metabolic state present in this pathologic disorder through its metabolic mechanisms of action. {\circledC} 2017 American Congress of Rehabilitation Medicine",
author = "M Vitali and {Naim Rodriguez}, N and Alberto Pedretti and A Drossinos and P Pironti and {Di Carlo}, G and G Fraschini",
year = "2018",
doi = "10.1016/j.apmr.2017.10.025",
language = "English",
volume = "99",
pages = "873--879",
journal = "Archives of Physical Medicine and Rehabilitation",
issn = "0003-9993",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Bone Marrow Edema Syndrome of the Medial Femoral Condyle Treated With Extracorporeal Shock Wave Therapy: A Clinical and MRI Retrospective Comparative Study

AU - Vitali, M

AU - Naim Rodriguez, N

AU - Pedretti, Alberto

AU - Drossinos, A

AU - Pironti, P

AU - Di Carlo, G

AU - Fraschini, G

PY - 2018

Y1 - 2018

N2 - Objective: To determine the validity of extracorporeal shock wave therapy (ESWT) in the treatment of bone marrow edema (BME) of the medial condyle of the knee. Design: Retrospective. Setting: Orthopedic Surgery outpatient clinic. Participants: Symptomatic patients (N=56) affected by BME of the medial condyle of the knee. Patients were equally divided into an ESWT-treated group and a control group, which was managed conservatively. Interventions: ESWT delivery to the medial condyle of the affected knee. Main Outcome Measures: Clinical and functional assessment of the knee was performed with the use of the clinical and functional scores of the Knee Society Score (KSS). Pain was measured with the visual analog scale (VAS). BME area was measured with magnetic resonance imaging (MRI) before treatment and at 4 months’ follow-up. Results: Clinical evaluation of patients at final follow-up of 4 months posttreatment showed a significant improvement (P <.0001) of symptoms and knee functionality, both for range of motion and strength in both groups. VAS values were significantly improved (P <.0001) in both groups, with 3 patients in the ESWT group being pain-free (VAS=0) at 4 months’ follow-up. At 4 months, MRI assessments on both sagittal and coronal views showed a significant reduction in BME in the ESWT group compared with the control group. Conclusions: Our findings show that ESWT is a valid nonpharmacologic and noninvasive therapy for spontaneous BME of the medial condyle that improves the affected vascular and metabolic state present in this pathologic disorder through its metabolic mechanisms of action. © 2017 American Congress of Rehabilitation Medicine

AB - Objective: To determine the validity of extracorporeal shock wave therapy (ESWT) in the treatment of bone marrow edema (BME) of the medial condyle of the knee. Design: Retrospective. Setting: Orthopedic Surgery outpatient clinic. Participants: Symptomatic patients (N=56) affected by BME of the medial condyle of the knee. Patients were equally divided into an ESWT-treated group and a control group, which was managed conservatively. Interventions: ESWT delivery to the medial condyle of the affected knee. Main Outcome Measures: Clinical and functional assessment of the knee was performed with the use of the clinical and functional scores of the Knee Society Score (KSS). Pain was measured with the visual analog scale (VAS). BME area was measured with magnetic resonance imaging (MRI) before treatment and at 4 months’ follow-up. Results: Clinical evaluation of patients at final follow-up of 4 months posttreatment showed a significant improvement (P <.0001) of symptoms and knee functionality, both for range of motion and strength in both groups. VAS values were significantly improved (P <.0001) in both groups, with 3 patients in the ESWT group being pain-free (VAS=0) at 4 months’ follow-up. At 4 months, MRI assessments on both sagittal and coronal views showed a significant reduction in BME in the ESWT group compared with the control group. Conclusions: Our findings show that ESWT is a valid nonpharmacologic and noninvasive therapy for spontaneous BME of the medial condyle that improves the affected vascular and metabolic state present in this pathologic disorder through its metabolic mechanisms of action. © 2017 American Congress of Rehabilitation Medicine

U2 - 10.1016/j.apmr.2017.10.025

DO - 10.1016/j.apmr.2017.10.025

M3 - Article

VL - 99

SP - 873

EP - 879

JO - Archives of Physical Medicine and Rehabilitation

JF - Archives of Physical Medicine and Rehabilitation

SN - 0003-9993

IS - 5

ER -